Injectable buprenorphine study suggests benefit in rapid induction

Results of a newly published study suggest that patients with moderate to severe opioid use disorder (OUD) could benefit from a rapid induction protocol in which they receive a same‐day dose of injectable buprenorphine.

Authors

Publication Details

Journal
Alcoholism & Drug Abuse Weekly
Published
2025-10-17
DOI
https://doi.org/10.1002/adaw.34686
Primary Topic
Opioid Use Disorder Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Injectable buprenorphine study suggests benefit in rapid induction

Gary A. Enos
Alcoholism & Drug Abuse Weekly
Opioid Use Disorder Treatment
article

Injectable buprenorphine study suggests benefit in rapid induction

Gary A. Enos
article en

Abstract

Results of a newly published study suggest that patients with moderate to severe opioid use disorder (OUD) could benefit from a rapid induction protocol in which they receive a same‐day dose of injectable buprenorphine.

Alcoholism & Drug Abuse WeeklyVol. 37(40)
Openalex Percentile: Top 60%
Opioid Use Disorder Treatment
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Injectable buprenorphine study suggests benefit in rapid induction — Gary A. Enos · Alcoholism & Drug Abuse Weekly (2025) | TGRS Research Map | TGRS